Abstract: Checkpoint inhibitor pneumonitis (CIP) imposes substantial mortality risk in malignant tumor patients receiving immune checkpoint inhibitors (ICIs) therapy. Although computed tomography (CT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback